Call to action on use and reimbursement for home blood pressure monitoring: A joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association

被引:180
|
作者
Pickering, Thomas G.
Miller, Nancy Houston
Ogedegbe, Gbenga
Krakoff, Lawrence R.
Artinian, Nancy T.
Goff, David
机构
关键词
AHA Scientific Statements; blood pressure; hypertension; patients;
D O I
10.1097/01.JCN.0000317429.98844.04
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Home blood pressure monitoring (HBPM) overcomes many of the limitations of traditional office blood pressure (BP) measurement and is both cheaper and easier to perform than ambulatory BP monitoring. Monitors that use the oscillometric method are currently available that are accurate, reliable, easy to use, and relatively inexpensive. An increasing number of patients are using them regularly to check their BP at home, but although this has been endorsed by national and international guidelines, detailed recommendations for their use have been lacking. There is a rapidly growing literature showing that measurements taken by patients at home are often lower than readings taken in the office and closer to the average BP recorded by 24-hour ambulatory monitors, which is the BP that best predicts cardiovascular risk. Because of the larger numbers of readings that can be taken by HBPM than in the office and the elimination of the white-coat effect (the increase of BP during an office visit), home readings are more reproducible than office readings and show better correlations with measures of target organ damage. In addition, prospective studies that have used multiple home readings to express the true BP have found that home BP predicts risk better than office BP (Class IIa; Level of Evidence A), This call-to-action article makes the following recommendations: (1) It is recommended that HBPM should become a routine component of BP measurement in the majority of patients with known or suspected hypertension; (2) Patients should be advised to purchase oscillometric monitors that measure BP on the upper arm with an appropriate cuff size and that have been shown to be accurate according to standard international protocols. They should be shown how to use them by their healthcare providers; (3) Two to 3 readings should be taken while the subject is resting in the seated position, both in the morning and at night, over a period of 1 week. A total of :12 readings are recommended for making clinical decisions; (4) HBPM is indicated in patients with newly diagnosed or suspected hypertension, in whom it may distinguish between white-coat and sustained hypertension. if the results are equivocal, ambulatory BP monitoring may help to establish the diagnosis; (5) In patients with prehypertension, HBPM may be useful for detecting masked hypertension; (6) HBPM is recommended for evaluating the response to any type of antihypertensive treatment and may improve adherence; (7) The target HBPM goal for treatment is < 135/85 mm Hg or < 130/80 mm Hg in high-risk patients; (8) HBPM is useful in the elderly, in whom both BP variability and the white-coat effect are increased; (9) HBPM is of value in patients with diabetes, in whom tight BP control is of paramount importance; (10) Other populations in whom HBPM may be beneficial include pregnant women, children, and patients with kidney disease; and (11) HBPM has the potential to improve the quality of care while reducing costs and should be reimbursed.
引用
收藏
页码:299 / 323
页数:25
相关论文
共 50 条
  • [21] Data Interoperability for Ambulatory Monitoring of Cardiovascular Disease: A Scientific Statement From the American Heart Association
    Armoundas, Antonis A.
    Ahmad, Faraz S.
    Bennett, Derrick A.
    Chung, Mina K.
    Davis, Leslie L.
    Dunn, Jessilyn
    Narayan, Sanjiv M.
    Slotwiner, David J.
    Wiley, Kevin Keith
    Khera, Rohan
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2024, 17 (03): : e000095
  • [22] Preventing cardiovascular disease and diabetes - A call to action from the American Diabetes Association and the American Heart Association
    Eckel, Robert H.
    Kahn, Richard
    Robertson, Rose Marie
    Rizza, Robert A.
    DIABETES CARE, 2006, 29 (07) : 1697 - 1699
  • [23] Treatment of Hypertension in Patients With Coronary Artery Disease A Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension
    Rosendorff, Clive
    Lackland, Daniel T.
    Allison, Matthew
    Aronow, Wilbert S.
    Black, Henry R.
    Blumenthal, Roger S.
    Cannon, Christopher P.
    de Lemos, James A.
    Elliott, William J.
    Findeiss, Laura
    Gersh, Bernard J.
    Gore, Joel M.
    Levy, Daniel
    Long, Janet B.
    O'Connor, Christopher M.
    O'Gara, Patrick T.
    Ogedegbe, Gbenga
    Oparil, Suzanne
    White, William B.
    Assoc, Amer Heart
    HYPERTENSION, 2015, 65 (06) : 1372 - 1407
  • [24] Treatment of Hypertension in Patients With Coronary Artery Disease A Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension
    Rosendorff, Clive
    Lackland, Daniel T.
    Allison, Matthew
    Aronow, Wilbert S.
    Black, Henry R.
    Blumenthal, Roger S.
    Cannon, Christopher P.
    de Lemos, James A.
    Elliott, William J.
    Findeiss, Laura
    Gersh, Bernard J.
    Gore, Joel M.
    Levy, Daniel
    Long, Janet B.
    O'Connor, Christopher M.
    O'Gara, Patrick T.
    Ogedegbe, Gbenga
    Oparil, Suzanne
    White, William B.
    CIRCULATION, 2015, 131 (19) : E435 - E470
  • [25] Cardiovascular Health in American Indians and Alaska Natives: A Scientific Statement From the American Heart Association
    Breathett, Khadijah
    Sims, Mario
    Gross, Marie
    Jackson, Elizabeth A.
    Jones, Emily J.
    Navas-Acien, Ana
    Taylor, Herman
    Thomas, Kevin L.
    Howard, Barbara, V
    CIRCULATION, 2020, 141 (25) : E948 - E959
  • [26] Implementation Strategies to Improve Blood Pressure Control in the United States: A Scientific Statement From the American Heart Association and American Medical Association
    Abdalla, Marwah
    Bolen, Shari D.
    Brettler, Jeffrey
    Egan, Brent M.
    Ferdinand, Keith C.
    Ford, Cassandra D.
    Lackland, Daniel T.
    Wall, Hilary K.
    Shimbo, Daichi
    HYPERTENSION, 2023, 80 (10) : E143 - E157
  • [27] Impact of the 2022 American Heart Association pediatric ambulatory blood pressure monitoring statement on the diagnosis of hypertension
    Sharma, Ajay P.
    Kirpalani, Amrit
    Sharma, Ajaya
    Altamirano-Diaz, Luis
    Filler, Guido
    Norozi, Kambiz
    PEDIATRIC NEPHROLOGY, 2023, 38 (08) : 2741 - 2751
  • [28] Impact of the 2022 American Heart Association pediatric ambulatory blood pressure monitoring statement on the diagnosis of hypertension
    Ajay P. Sharma
    Amrit Kirpalani
    Ajaya Sharma
    Luis Altamirano-Diaz
    Guido Filler
    Kambiz Norozi
    Pediatric Nephrology, 2023, 38 : 2741 - 2751
  • [29] Pulmonary Hypertension in Congenital Heart Disease: A Scientific Statement From the American Heart Association
    Jone, Pei-Ni
    Ivy, D. Dunbar
    Hauck, Amanda
    Karamlou, Tara
    Truong, Uyen
    Coleman, Ryan D.
    Sandoval, Juan Pablo
    del Cerro Marin, Maria Jesus
    Eghtesady, Pirooz
    Tillman, Kathryn
    Krishnan, Usha S.
    CIRCULATION-HEART FAILURE, 2023, 16 (07)
  • [30] Orthostatic Hypotension in Adults With Hypertension: A Scientific Statement From the American Heart Association
    Juraschek, Stephen P.
    Cortez, Melissa M.
    Flack, John M.
    Ghazi, Lama
    Kenny, Rose Anne
    Rahman, Mahboob
    Spikes, Telisa
    Shibao, Cyndya A.
    Biaggioni, Italo
    HYPERTENSION, 2024, 81 (03) : e16 - e30